Pyrimidine inhibitors synergize with nucleoside analogues to block SARS-CoV-2

D. Schultz(University of Pennsylvania), Robert M. Johnson(University of Maryland, Baltimore), Kasirajan Ayyanathan(University of Pennsylvania), Jesse Miller(University of Pennsylvania), Kanupriya Whig(University of Pennsylvania), Brinda Kamalia(University of Pennsylvania), Mark Dittmar(University of Pennsylvania), Stuart Weston(University of Maryland, Baltimore), Holly Hammond(University of Maryland, Baltimore), Carly Dillen(University of Maryland, Baltimore), Jeremy Ardanuy(University of Maryland, Baltimore), Louis J. Taylor(University of Maryland, Baltimore), Jae Seung Lee(University of Pennsylvania), Minghua Li(University of Pennsylvania), Emily M. Lee(National Institutes of Health), Clarissa Shoffler(University of Pennsylvania), Christopher Petucci(University of Pennsylvania), Samuel Constant, Marc Ferrer(National Institutes of Health), Christoph A. Thaiss(University of Pennsylvania), Matthew B. Frieman(University of Maryland, Baltimore), Sara Cherry(University of Pennsylvania)
Nature
February 7, 2022
10.1038/s41586-022-04482-x
Cited by 199Open Access
Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis